WG
MGNX icon

Winton Group’s MacroGenics MGNX Stock Holding History

Winton Group’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-16,333
Closed -$157K – 774
2023
Q4 		$157K Sell
16,333
-15,314
-48% -$106K 0.01% 666
2023
Q3 		$147K Buy
+31,647
New +$158K 0.01% 697
2021
Q4 		– Sell
-17,795
Closed -$373K – 1254
2021
Q3 		$373K Buy
17,795
+5,141
+41% +$124K 0.02% 1005
2021
Q2 		$340K Sell
12,654
-2,640
-17% -$77.3K 0.02% 1125
2021
Q1 		$487K Sell
15,294
-979
-6% -$23.8K 0.03% 906
2020
Q4 		$372K Buy
+16,273
New +$375K 0.03% 943

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Winton Group's MGNX Position: Q1 2024 in Review

Winton Group sold out of MacroGenics (MGNX) in Q1 2024, closing a stake of 16,333 shares — an estimated $157K sold.

Winton Group first reported a position in MGNX in Q4 2020 and held it in 6 quarters. The position peaked at $487K in Q1 2021. 163 funds tracked by Wall St. Rank hold MGNX as of Q1 2024.

  • Winton Group reported no remaining MacroGenics position as of Q1 2024 after selling out during the quarter.
  • Winton Group sold 16,333 MacroGenics shares in Q1 2024, an estimated $157K.
  • Winton Group first reported a position in MacroGenics in Q4 2020 and held it in 6 quarters.
  • Winton Group's MacroGenics position peaked at $487K in Q1 2021.
  • 163 funds tracked by Wall St. Rank held MacroGenics as of Q1 2024.

Based on Winton Group's 13F filing for Q1 2024, filed 14 May 2024.